Mesotherapy With Bicalutamide: A New Treatment for Androgenetic Alopecia

    January 2023 in “ International Journal of Trichology ”
    Alba Gomez-Zubiaur, JuanJose Andres-Lencina, Víctor Cabezas … JoseMaria Ricart
    Studysummary This study found that bicalutamide mesotherapy resulted in subtle hair density improvements and was well tolerated by premenopausal women with androgenetic alopecia.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on ijtrichology.com →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Bicalutamide: A Potential New Oral Antiandrogenic Drug for Female Pattern Hair Loss Journal of The American Academy of Dermatology · 2020
    2. Safety of Oral Bicalutamide in Female Pattern Hair Loss: A Retrospective Review of 316 Patients Journal of The American Academy of Dermatology · 2020
    3. Efficacy of Intralesional and Oral Dutasteride in the Treatment of Androgenetic Alopecia: A Systematic Review Skin appendage disorders · 2020
    4. Mesotherapy with Dutasteride in the Treatment of Androgenetic Alopecia International Journal of Trichology · 2017